The Sonoma Valley Unified School District Board of Trustees held a wide-ranging study session on school consolidation on Tuesday and could decide which schools, if any, to close within the next two ...

2 The open-label, phase 1 trial of bel-sar is structured in 2 parts. In part 1, 5 patients with low-grade NMIBC were treated with single dose bel-sar without light activation. Part 2 of the study is ...

The 1:1 ratio results from the way the X and Y chromosomes are doled out in sperm and eggs. We know that boys and girls are produced in much the same frequency. But how – and why – is this 1:1 ...

Rochester Business Journal, the leading source of business news and information in Rochester, N.Y., since 1987, and its sister publication, The Daily Record, which covers law and real estate in ...

Democrat Sen. John Cronin is seeking a third term as state senator for the Worcester & Middlesex District. The district covers the cities of Fitchburg and Leominster and the towns of Clinton ...

“The language in the USCIS Policy Manual clarification on F-1 participation in a study abroad program is not intended to be a change to, or deviation from, SEVP’s longstanding interpretation regarding ...

Get up to speed on the weird world of AI in just six editions of our new free newsletter. It feels as though AI is moving a million miles a minute. Every week, it seems, there are product launches ...

while remaining life expectancy at age 50 was 1.45 years higher. Our study shows a worrying trend for people born from the 1970s onwards. This is true in all English-speaking countries ...

John Henry Newman, who is considered a forerunner ... Catholic Church’s ongoing Synod on Synodality — and as a vital guide for following a sound theological road map for synodality today.

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The Christian Science Church, and we’ve always been transparent about that. The Church publishes the ...

has announced the Phase 1 results for Ribrecabtagene autoleucel (DRL-1801) from the SWASTH study – India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with ...